A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
Open Access
- 1 June 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 18 (6), 1899-1904
- https://doi.org/10.1681/asn.2007020166
Abstract
Idiopathic membranous nephropathy (IMN) is the most common cause of nephrotic syndrome in adults. Universal consensus regarding the need for and the modality of therapy has not been formed because of a lack of controlled trials of sufficient size, quality, and duration. This study compared the effect of a 6-mo course of alternating prednisolone and cyclophosphamide with supportive treatment in adults with nephrotic syndrome caused by IMN on doubling of serum creatinine, development of ESRD, and quality of life in a randomized, controlled trial. Patients were followed up for 10 yr. Data were analyzed on an intention-to-treat basis. A total of 93 patients completed the study. Of the 47 patients who received the experimental protocol, 34 achieved remission (15 complete and 19 partial), compared with 16 (five complete, 11 partial) of 46 in the control group (P < 0.0001). The 10-yr dialysis-free survival was 89 and 65% (P = 0.016), and the likelihood of survival without death, dialysis, and doubling of serum creatinine were 79 and 44% (P = 0.0006) in the two groups. Treated patients exhibited significantly lower prevalence of edema, hypertension, hypoalbuminemia, hyperlipidemia that required therapy, angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use, and better quality of life on follow-up. The incidence of infections was similar in the two groups. In conclusion, untreated IMN with nephrotic syndrome is associated with a high risk for deterioration of renal function. A 6-mo regimen of cyclophosphamide and steroids induces remissions in a high proportion, arrests progression of renal insufficiency, and improves quality of life.Keywords
This publication has 26 references indexed in Scilit:
- A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous NephropathyAmerican Journal of Kidney Diseases, 2006
- Idiopathic membranous nephropathy: Definition and relevance of a partial remissionKidney International, 2004
- The treatment of idiopathic membranous nephropathy: A dilemma or a conundrum?American Journal of Kidney Diseases, 2004
- Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic reviewAmerican Journal of Kidney Diseases, 2004
- Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rateNephrology Dialysis Transplantation, 2004
- Alternative therapies and future intervention for treatment of membranous nephropathySeminars in Nephrology, 2003
- A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- Steroids and Cytotoxic Drugs in the Treatment of Membranous GlomerulopathyNephron, 1988
- Controlled trial of cyclophosphamide in idiopathic membranous nephropathyKidney International, 1974